Linking the glycosylation pathway to the strict regulation of PD-1/PD-L1 and further elucidating the molecular mechanisms related to glycosylation may provide clues for the discovery of immunotherapeutic targets for tumor therapy and new strategies to improve the efficacy of cancer immunotherapy. Here, CD274 is linked to cancer.